269 related articles for article (PubMed ID: 33463233)
21. Applications of Two-Dimensional Nanomaterials in Breast Cancer Theranostics.
Mohammadpour Z; Majidzadeh-A K
ACS Biomater Sci Eng; 2020 Apr; 6(4):1852-1873. PubMed ID: 33455353
[TBL] [Abstract][Full Text] [Related]
22. Design and Functionalization of the NIR-Responsive Photothermal Semiconductor Nanomaterials for Cancer Theranostics.
Huang X; Zhang W; Guan G; Song G; Zou R; Hu J
Acc Chem Res; 2017 Oct; 50(10):2529-2538. PubMed ID: 28972736
[TBL] [Abstract][Full Text] [Related]
23. Nanomedicine-based adjuvant therapy: a promising solution for lung cancer.
Xu Y; Hsu JC; Xu L; Chen W; Cai W; Wang K
J Nanobiotechnology; 2023 Jul; 21(1):211. PubMed ID: 37415158
[TBL] [Abstract][Full Text] [Related]
24. Theranostics Aspects of Various Nanoparticles in Veterinary Medicine.
Bai DP; Lin XY; Huang YF; Zhang XF
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30352960
[TBL] [Abstract][Full Text] [Related]
25. Nanomaterials: a promising multimodal theranostics platform for thyroid cancer.
Li L; Wang Z; Guo H; Lin Q
J Mater Chem B; 2023 Sep; 11(32):7544-7566. PubMed ID: 37439780
[TBL] [Abstract][Full Text] [Related]
26. Engineered nano-immunopotentiators efficiently promote cancer immunotherapy for inhibiting and preventing lung metastasis of melanoma.
Luo L; Iqbal MZ; Liu C; Xing J; Akakuru OU; Fang Q; Li Z; Dai Y; Li A; Guan Y; Wu A
Biomaterials; 2019 Dec; 223():119464. PubMed ID: 31525691
[TBL] [Abstract][Full Text] [Related]
27. Two-dimensional cancer theranostic nanomaterials: Synthesis, surface functionalization and applications in photothermal therapy.
Murugan C; Sharma V; Murugan RK; Malaimegu G; Sundaramurthy A
J Control Release; 2019 Apr; 299():1-20. PubMed ID: 30771414
[TBL] [Abstract][Full Text] [Related]
28. Magnetic nanoparticles in theranostics of malignant melanoma.
Shevtsov M; Kaesler S; Posch C; Multhoff G; Biedermann T
EJNMMI Res; 2021 Dec; 11(1):127. PubMed ID: 34905138
[TBL] [Abstract][Full Text] [Related]
29. Biomolecule-functionalized nanoformulations for prostate cancer theranostics.
Pranav ; Laskar P; Jaggi M; Chauhan SC; Yallapu MM
J Adv Res; 2023 Sep; 51():197-217. PubMed ID: 36368516
[TBL] [Abstract][Full Text] [Related]
30. Nanomedicine and its applications to the treatment of prostate cancer.
Ouvinha de Oliveira R; de Santa Maria LC; Barratt G
Ann Pharm Fr; 2014 Sep; 72(5):303-16. PubMed ID: 25220226
[TBL] [Abstract][Full Text] [Related]
31. Nanotechnology and nanomedicine: going small means aiming big.
Teli MK; Mutalik S; Rajanikant GK
Curr Pharm Des; 2010 Jun; 16(16):1882-92. PubMed ID: 20222866
[TBL] [Abstract][Full Text] [Related]
32. The application of multifunctional nanomaterials in Alzheimer's disease: A potential theranostics strategy.
Xu Y; Zhao M; Zhou D; Zheng T; Zhang H
Biomed Pharmacother; 2021 May; 137():111360. PubMed ID: 33582451
[TBL] [Abstract][Full Text] [Related]
33. Malignant melanoma.
Lang PG
Med Clin North Am; 1998 Nov; 82(6):1325-58. PubMed ID: 9889751
[TBL] [Abstract][Full Text] [Related]
34. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
[TBL] [Abstract][Full Text] [Related]
35. Nanosystems for Improved Targeted Therapies in Melanoma.
Beiu C; Giurcaneanu C; Grumezescu AM; Holban AM; Popa LG; Mihai MM
J Clin Med; 2020 Jan; 9(2):. PubMed ID: 31979325
[TBL] [Abstract][Full Text] [Related]
36. David versus Goliath: Radiotheranostic nanomedicine as a weapon against melanoma.
Filippi L; Frantellizzi V; De Vincentis G
Cancer Treat Res Commun; 2021; 29():100478. PubMed ID: 34689017
[TBL] [Abstract][Full Text] [Related]
37. Emerging theranostics to combat cancer: a perspective on metal-based nanomaterials.
Agnihotri TG; Gomte SS; Jain A
Drug Dev Ind Pharm; 2022 Nov; 48(11):585-601. PubMed ID: 36448770
[TBL] [Abstract][Full Text] [Related]
38. Advances of functional nanomaterials for cancer immunotherapeutic applications.
Hao Y; Zhou X; Li R; Song Z; Min Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1574. PubMed ID: 31566896
[TBL] [Abstract][Full Text] [Related]
39. Melanoma treatment: from conventional to nanotechnology.
Mishra H; Mishra PK; Ekielski A; Jaggi M; Iqbal Z; Talegaonkar S
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2283-2302. PubMed ID: 30094536
[TBL] [Abstract][Full Text] [Related]
40. Functionalized Graphene Oxide for Chemotherapeutic Drug Delivery and Cancer Treatment: A Promising Material in Nanomedicine.
Sharma H; Mondal S
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
